Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ertapenem:Susc:Pt:Isolate:OrdQn:MIC

Known as: Ertapenem [Susceptibility] by Minimum inhibitory concentration (MIC), Ertapenem:Susc:Pt:Isolato:OrdQn:MIC, Ertapenem:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Minimum Inhibitory Concentration 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
 
Is this relevant?
2016
2016
ABSTRACT The minimal concentration of antibiotic required to inhibit the growth of different isolates of a given species with no… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2013
2013
ABSTRACT Enterobacteriaceae producing the OXA-48 carbapenemase are emerging worldwide, leaving few treatment options. Efficacy… Expand
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2012
2012
ABSTRACT A retrospective study was conducted at two medical centers in Taiwan to evaluate the clinical characteristics, outcomes… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
For 244 patients with bacteremia due to extended-spectrum β-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae… Expand
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2009
2009
Ertapenem, a Group 1 carbapenem, is most recently introduced into the market. It is a beta-lactam antibiotic that possesses a… Expand
Is this relevant?
2007
2007
ZusammenfassungGRUNDLAGEN: Infektionen sind die häufigsten Komplikationen nach Organtransplantationen. Bakterien gehören zu den h… Expand
Is this relevant?
2002
2002
This study compared the in vitro activities of ertapenem (Merck & Co., Inc.), ceftriaxone, amoxicillin-clavulanate, and… Expand
Is this relevant?